Trial Profile
Mixture of Liposomal Bupivicaine and Bupivicaine Hydrogen Chloride (HCl) May Provide Faster and Longer Lasting Analgesia in Transversus Abdominis Block for Patient Having Open Abdominal Hysterectomies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 11 Jan 2021 Results published in the Canadian Journal of Anesthesia
- 20 Feb 2019 Status changed from recruiting to completed.
- 16 Aug 2017 New trial record